Efficient Nef-mediated downmodulation of TCR-CD3 and CD28 is associated with high CD4+ T cell counts in viremic HIV-2 infection

J Virol. 2012 May;86(9):4906-20. doi: 10.1128/JVI.06856-11. Epub 2012 Feb 15.

Abstract

The role of the multifunctional accessory Nef protein in the immunopathogenesis of HIV-2 infection is currently poorly understood. Here, we performed comprehensive functional analyses of 50 nef genes from 21 viremic (plasma viral load, >500 copies/ml) and 16 nonviremic (<500) HIV-2-infected individuals. On average, nef alleles from both groups were equally active in modulating CD4, TCR-CD3, CD28, MHC-I, and Ii cell surface expression and in enhancing virion infectivity. Thus, many HIV-2-infected individuals efficiently control the virus in spite of efficient Nef function. However, the potency of nef alleles in downmodulating TCR-CD3 and CD28 to suppress the activation and apoptosis of T cells correlated with high numbers of CD4(+) T cells in viremic patients. No such correlations were observed in HIV-2-infected individuals with undetectable viral load. Further functional analyses showed that the Nef-mediated downmodulation of TCR-CD3 suppressed the induction of Fas, Fas-L, PD-1, and CTLA-4 cell surface expression as well as the secretion of gamma interferon (IFN-γ) by primary CD4(+) T cells. Moreover, we identified a single naturally occurring amino acid variation (I132T) in the core domain of HIV-2 Nef that selectively disrupts its ability to downmodulate TCR-CD3 and results in functional properties highly reminiscent of HIV-1 Nef proteins. Taken together, our data suggest that the efficient Nef-mediated downmodulation of TCR-CD3 and CD28 help viremic HIV-2-infected individuals to maintain normal CD4(+) T cell homeostasis by preventing T cell activation and by suppressing the induction of death receptors that may affect the functionality and survival of both virally infected and uninfected bystander cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution
  • Apoptosis / genetics
  • CD28 Antigens / metabolism*
  • CD4 Lymphocyte Count*
  • Cell Line
  • Down-Regulation / immunology
  • Gene Expression
  • Gene Order
  • HIV Infections / immunology*
  • HIV Infections / metabolism
  • HIV-2 / genetics
  • HIV-2 / immunology
  • HIV-2 / metabolism*
  • Humans
  • Leukocytes, Mononuclear / metabolism
  • Leukocytes, Mononuclear / virology
  • Lymphocyte Activation / genetics
  • Models, Molecular
  • Molecular Sequence Data
  • Phylogeny
  • Protein Binding / immunology
  • Protein Conformation
  • Proviruses / genetics
  • Receptor-CD3 Complex, Antigen, T-Cell / chemistry
  • Receptor-CD3 Complex, Antigen, T-Cell / metabolism*
  • Receptors, Cell Surface / metabolism
  • Receptors, Death Domain / metabolism
  • T-Lymphocytes / immunology
  • Viremia / immunology
  • Viremia / metabolism
  • nef Gene Products, Human Immunodeficiency Virus / chemistry
  • nef Gene Products, Human Immunodeficiency Virus / genetics
  • nef Gene Products, Human Immunodeficiency Virus / metabolism*

Substances

  • CD28 Antigens
  • Receptor-CD3 Complex, Antigen, T-Cell
  • Receptors, Cell Surface
  • Receptors, Death Domain
  • nef Gene Products, Human Immunodeficiency Virus

Associated data

  • GENBANK/JQ746624
  • GENBANK/JQ746625
  • GENBANK/JQ746626
  • GENBANK/JQ746627
  • GENBANK/JQ746628
  • GENBANK/JQ746629
  • GENBANK/JQ746630
  • GENBANK/JQ746631
  • GENBANK/JQ746632
  • GENBANK/JQ746633
  • GENBANK/JQ746634
  • GENBANK/JQ746635
  • GENBANK/JQ746636
  • GENBANK/JQ746637
  • GENBANK/JQ746638
  • GENBANK/JQ746639
  • GENBANK/JQ746640
  • GENBANK/JQ746641
  • GENBANK/JQ746642
  • GENBANK/JQ746643
  • GENBANK/JQ746644